Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 26/5/2020
SIETES contiene 93011 citas

 1 a 20 de 236 siguiente >>
Presentar resultados
Seleccionar todas
2.Enlace a cita original Cita con resumen
Taylor P. J&J hit by $8bn judgment for man claiming breast growth due to Risperdal. PMLiVE 2019:9 de octubre. [Ref.ID 103192]
4.Enlace a cita original
Nielen JTH, de Vries F, Dagnelie PC, van den Bemt BJF, Emans PJ, Lalmohamed A, de Boer A, Boonen A. Use of thiazolidinediones and the risk of elective hip or knee replacement: a population based case–control study. Br J Clin Pharmacol 2016;81:370-8. [Ref.ID 100098]
5. Cita con resumen
Carson JL, Sieber F, Cook DR, Hoover DR, Noveck H, Chaitman BR, Fleisher L, Beaupre L, Macaulay W, Rhoads GG, Paris B, Zagorin A, Wanders DW, Zakriya KJ, Magaziner J. Liberal versus restrictive blood transfusion strategy: 3-year survival and cause of death results from the FOCUS randomised controlled trial. Lancet 2015;385:1183-9. [Ref.ID 98991]
6. Cita con resumen
Anónimo. Stryker announces $1B settlement in hip implant class-action suit. DIA Daily 2014:4 de noviembre. [Ref.ID 98275]
7.Tiene citas relacionadas Cita con resumen
Michaëlsson K. Surgeon volume and complications after total hip arthroplasty. BMJ 2014;348:g3433. [Ref.ID 98024]
8.Tiene citas relacionadas Cita con resumen
Mäkelä KT, Matilainen M, Pulkkinen P, Fenstad AM, Havelin L, Engesaeter L, Furnes O, Pederson AB, Overgaard S, Kärrholm J, Malchau H, Garellick G, Ranstam J, Eskelinen A. Failure rate of cemented and uncemented total hip replacements: register study of combined Nordic database of four nations. BMJ 2014;348:14. [Ref.ID 97252]
9.Tiene citas relacionadas
Hamilton DF, Howie CR. Selecting the right hip replacement. BMJ 2014;348:g46. [Ref.ID 97250]
10. Cita con resumen
Kynaston-Pearson F, Ashmore AM, Malak TT, Rombach I, Taylor A, Beard D, Arden NK, Price A, Prieto-Alhambra D, Judge A, Carr AJ, Glyn-Jones S. Primary hip replacement prostheses and their evidence base: systematic review of literature. BMJ 2014;347:f6956. [Ref.ID 97210]
11. Cita con resumen
Wise J. Death rate from hip replacement almost halved in eight years. BMJ 2013;347:5. [Ref.ID 96344]
12.Tiene citas relacionadas Cita con resumen
Hunt LP, Ben-Shlomo Y, Clark EM, Dieppe P, Judge A, MacGregor AJ, Tobias JH, Vernon K, Blom AW, on behalf of the National Joint Registry for England Wales and Northern Ireland. 90-day mortality after 409 096 total hip replacements for osteoarthritis, from the National Joint Registry for England and Wales: a retrospective analysis. Lancet 2013;382:1097-104. [Ref.ID 96311]
13.Tiene citas relacionadas Cita con resumen
Issa K, Mont MA. Total hip replacement: mortality and risks. Lancet 2013;382:1074-6. [Ref.ID 96310]
14. Cita con resumen
Pennington M, Grieve R, Sekhon JS, Gregg P, Black N, van der Meulen JH. Cemented, cementless, and hybrid protheses for total hip replacement: cost effectiveness analysis. BMJ 2013;346:12. [Ref.ID 95410]
15. Cita con resumen
Anónimo. FDA approves first retinal implant for adults with rare genetic eye disease. U.S. Food and Drug Administration 2013:14 de febrero. [Ref.ID 94699]
16.Enlace a cita original Cita con resumen
Anónimo. FDA safety communication: metal-on-metal hip implants. U.S. Food and Drug Administration 2013:17 de enero. [Ref.ID 94630]
17. Cita con resumen
Lalmohamed A, Vestergaard P, Klop C, Grove EL, de Voer A, Leufkens HGM, van Staa TP, de Vries F. Timing of acute myocardial infarction in patients undergoing total hip or knee replacement. A nationwide cohort study. Arch Intern Med 2012;172:1229-35. [Ref.ID 94317]
19.Tiene citas relacionadas
Rosengren BE. Metal-on-metal hip implants and the risk of cancer. BMJ 2012;345:6. [Ref.ID 93598]
20. Cita con resumen
Anónimo. Stricter device regulation needed - Lessons from the past. Lancet 2012;379:2402. [Ref.ID 93335]
Seleccionar todas
 1 a 20 de 236 siguiente >>